Evropská unie -
čeština -
EMA (European Medicines Agency)
venclyxto
abbvie deutschland gmbh co. kg - venetoclax - leukémie, lymfocytární, chronická, b-buňka - antineoplastická činidla - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.
Evropská unie -
čeština -
EMA (European Medicines Agency)
viekirax
abbvie deutschland gmbh co. kg - ombitasvir, paritaprevir, ritonavir - hepatitida c, chronická - antivirotika pro systémové použití - viekirax je indikován v kombinaci s dalšími léčivými přípravky pro léčbu chronické hepatitidy c (chc) u dospělých. pro virus hepatitidy c (hcv) genotypu konkrétní činnosti.
Evropská unie -
čeština -
EMA (European Medicines Agency)
maviret
abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitida c, chronická - antivirotika pro systémové použití - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.
Evropská unie -
čeština -
EMA (European Medicines Agency)
quviviq
idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - poruchy spánku a poruchy při údržbě - psycholeptika - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
Česká republika -
čeština -
SUKL (Státní ústav pro kontrolu léčiv)
arufil 20mg/ml oční kapky, roztok
bausch + lomb ireland limited, dublin array - 18178 povidon k 30 - oční kapky, roztok - 20mg/ml - umĚlÉ slzy a jinÉ indiferentnÍ pŘÍpravky
Česká republika -
čeština -
SUKL (Státní ústav pro kontrolu léčiv)
salazopyrin en 500mg enterosolventní tableta
pfizer, spol. s r.o., praha array - 14014 sulfasalazin s povidonem - enterosolventní tableta - 500mg - sulfasalazin
Česká republika -
čeština -
SUKL (Státní ústav pro kontrolu léčiv)
sulfasalazin k-en 500mg enterosolventní tableta
krka, d.d., novo mesto, novo mesto array - 14014 sulfasalazin s povidonem - enterosolventní tableta - 500mg - sulfasalazin
Evropská unie -
čeština -
EMA (European Medicines Agency)
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastická činidla - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.